Professional Overview

Itziar Canamasas is a seasoned executive in the pharmaceutical industry, currently serving as the Global Head of Oncology, SVP at Boehringer Ingelheim, based in Basel, Switzerland. Her expertise spans oncology, global marketing, and leadership, with a strong focus on the pharmaceutical and biotechnology sectors.

Experience Summary

Current Role

As the Global Head of Oncology, SVP at Boehringer Ingelheim, Itziar Canamasas oversees the development and implementation of the company's oncology strategy. She is also a Strategic Advisor and Chairwoman at AtG Therapeutics, providing guidance on the company's growth and development. Her current position involves key responsibilities such as leading cross-functional teams, driving business growth, and fostering strategic partnerships.

Career Progression

Itziar Canamasas has a notable career progression, with previous roles including Chief Executive Officer at AtG Therapeutics, Head of Oncology Europe, Middle East and Africa at Bayer Pharmaceuticals, and VP Global Marketing Oncology at Bayer Pharmaceuticals. Her career trajectory demonstrates significant growth, with key achievements including leadership of high-performing teams, development of successful marketing strategies, and contributions to the growth of various pharmaceutical companies.

Areas of Expertise

Itziar Canamasas possesses industry-specific skills in oncology, marketing, and leadership, as well as technical competencies in strategy development, team management, and partnership building. Her leadership and management capabilities are evident in her ability to drive business growth, lead cross-functional teams, and foster strategic partnerships.

Professional Impact

Although specific projects or initiatives are not detailed, Itziar Canamasas' current and previous roles suggest a significant impact on the pharmaceutical industry, particularly in the oncology sector. Her leadership and expertise have likely contributed to the development and implementation of successful strategies, driving business growth and improving patient outcomes.

Conclusion

Itziar Canamasas is a seasoned executive with a strong track record of leadership and expertise in the pharmaceutical industry. Her current focus on oncology and global strategy is expected to continue driving growth and innovation in the sector. With her unique blend of industry knowledge, technical competencies, and leadership capabilities, Itziar Canamasas is poised to make a lasting impact on the pharmaceutical industry.